18-04-20 OpenHIE and SCM.pptx

14 views
Skip to first unread message

Derek Ritz

unread,
Apr 20, 2018, 11:34:29 AM4/20/18
to openhie-su...@googlegroups.com

Hi all – here is a high-level description (for discussion) of where the “connectors” might be between the HIE and the SCM system. 😊

18-04-20 OpenHIE and SCM.pptx

Chris Wright

unread,
Apr 20, 2018, 4:10:37 PM4/20/18
to Derek Ritz, openhie-su...@googlegroups.com
Hi Derek. 

In theory your description works, but only for single dose SKUs. The challenge in using a vaccination use case with a multi dose unit is that there will normally be open vial wastage compromised of unusable doses after the time period lapses for reuse of remaining doses in the vial. In some cases, an SKU of five-dose vial might only be used once before it must be disposed. Each antigen packaged in a multi dose vial has specific and perhaps unique reuse time restrictions as the antigen begins to degrade once the seal is broken. Some are limited to five hours, others to days. Open vial wastage should be reported for logistics reasons but rarely is due to human factors and perverse incentives. For quality of care, open vial wastage is preferable to turning away a single client in need of vaccination, but HCWs are sometimes penalized for be wasteful because open vial wastage (ok) and closed vial wastage (bad) are treated the same. 

TMI, I know. 

On Fri, Apr 20, 2018 at 16:34 Derek Ritz <derek...@ecgroupinc.com> wrote:

Hi all – here is a high-level description (for discussion) of where the “connectors” might be between the HIE and the SCM system. 😊

--
You received this message because you are subscribed to the Google Groups "OpenHIE Supply Chain" group.
To unsubscribe from this group and stop receiving emails from it, send an email to openhie-supply-c...@googlegroups.com.
To post to this group, send email to openhie-su...@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/openhie-supply-chain/33018c279aef48a2e31e8acda21db717%40mail.gmail.com.
For more options, visit https://groups.google.com/d/optout.
--
JSILogochris wrightRed Squares Practice Lead, Data Visibility & UseRed Squares CELL: +41.77.951.7144 | WWW.JSI.COM/SUPPLYCHAIN FBTwitter

Derek Ritz

unread,
Apr 20, 2018, 5:49:11 PM4/20/18
to Chris Wright, openhie-su...@googlegroups.com

Hi Chris.

 

Thanks for starting the discussion on this! Can I ask, though, why you think this approach would only work for single-dose GTINs? My example illustrated consumption based on a 100-dose pack (and assumed 50 doses wasted).

 

I agree – if we’re considering multi-dose vials, it is important to summarize vaccination transactions by DAY, because the vials are (often) not usable the next day. I tried to lay out a daily-consumption example in my deck to illustrate this… but obviously I didn’t do a good job of explaining it. So… here goes:

 

If GTIN-1 has 10 doses per vial of Vaccine-1 and we log in the HIE’s shared health record (SHR) that there were 42 vaccination events on April-20 then we can imply the number of vials by applying a “round up” to the next whole integer for vial consumption and then some modulo math to get open-vial wastage…

 

42 / 10 = 4.2 rounded up = 5 vials of GTIN-1 with 10 - 42mod10 = 8 open-vial doses wasted

 

If GTIN-2 has 5 doses per vial of the same Vaccine-1, then the modulo math gives…

 

42 / 5 = 8.4 rounded up = 9 vials of GTIN-2 with 5 – 42mod5 = 3 open-vial doses wasted

 

Of course, a place where an implied consumption approach doesn’t work well is when a facility has multiple GTINs of the same vaccine (which is not especially common… but happens sometimes). In places where there is a 1:1 relationship between GTIN and vaccine, the implied consumption heuristics yield pretty good results. In high-volume environments, we sometimes try to leverage multiple GTINs (e.g. lower price-per-dose 50-dose GTINs alongside higher-priced 5-dose GTINs) to reduce overall prices while still attempting to mitigate vaccine dose wastage.  Usefully, these high-volume clinics are also often the contexts where barcoding technologies can be adopted to explicitly track GTINs (and lots).

 

An implied consumption approach also does not work especially well when the attempt is made to summarize over a whole week or a whole month (or any time period longer than a vial can remain open). This is because of the issue you’ve identified, Chris. The systemic error such an approach introduces is illustrated by “lazily” trying to imply the weekly consumption of GTIN-2…

 

Monday: 42 doses

Tuesday: 35 doses

Wednesday: 36 doses

Thursday: 41 doses

Friday: 27 doses

---------------------------

Total: 181 doses

 

If I apply the heuristic across the entire summarized week…

 

181 / 5 = 36.2 rounded up = 37 vials of GTIN-2 with 5 – 181mod5 = 4 open-vial doses wasted

 

When actually we should have done a daily summaries to yield…

 

Monday: 9 vials with 3 doses wasted

Tuesday: 7 vials

Wednesday: 8 vials with 4 doses wasted

Thursday: 9 vials with 4 doses wasted

Friday: 6 vials with 3 doses wasted

---------------------------

Total: 39 vials of GTIN-2 with 21 open-vial doses wasted

 

I don’t think your example was TMI at all! We need to look at ways to leverage data from the HIE that will work in the contexts we are implementing them. I was not trying to be theoretical (in an academic way)… I was trying to illustrate an implied consumption heuristic that we could actually use.

 

Re: your comments about open-vial vs closed-vial wastage… the suggested algorithms could be leveraged to develop both of these from just the periodic physical stock-counts. Using the 1-week example from above…

 

Physical count of usable GTIN-2 at end of prior week: 100 vials

Physical count of usable GTIN-2 at end of current week: 56 vials

Closed-vial wastage = 100 – 39 – 56 = 5 vials of GTIN-2 = 25 closed-vial doses

 

Lastly, it is worth noting that these algorithms can support cost optimization. Over the course of a year, analytics could be employed to develop an economic model to inform which pack size (e.g. 5-dose GTIN-2, 10-dose GTIN-1, 20-dose GTIN-3) is the “right” one for each clinic, based on the clinic’s transaction volumes. There will be, for each clinic, a “sweet spot” where the lower price/dose of larger pack sizes trades off against the higher open-vial wastage to yield an optimal pack size.

 

Sorry if this was TLDR… but I’m hoping at least a few of our teammates will be willing to wade through all these examples!

 

Warmest regards,

Derek

 

Derek Ritz, P.Eng, CPHIMS-CA

ecGroup Inc.

+1 (905) 515-0045

This communication is intended only for the party to whom it is addressed, and may contain information which is privileged or confidential. Any other delivery, distribution, copying or disclosure is strictly prohibited and is not a waiver of privilege or confidentiality.

Chris Wright

unread,
Apr 21, 2018, 1:12:31 AM4/21/18
to Derek Ritz, openhie-su...@googlegroups.com
Thanks for the additional details, Derek. I see my error in missing the emphasis on the daily transaction data, which works, especially if we also get a periodic routine physical count of SKUs on hand.  I also totally agree about the ability to use derived open vial wastage to better target different vial sizes, and have made the same point in other fora. So we are aligned🙂
Reply all
Reply to author
Forward
0 new messages